NutriBand (NTRB) Enterprise Value Growth (1y) (2017 - 2026)
NutriBand (NTRB) Enterprise Value Growth (1y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
NutriBand |
41.21 Mn |
36.63 Mn |
88,941.00 |
| Date | Value |
|---|
| Jan 31, 2026 |
-6.10% |
| Oct 31, 2025 |
6.77% |
| Jul 31, 2025 |
-3.48% |
| Apr 30, 2025 |
64.49% |
| Jan 31, 2025 |
-774.69% |
| Oct 31, 2024 |
-350.33% |
| Jul 31, 2024 |
-189.56% |
| Apr 30, 2024 |
-553.15% |
| Jan 31, 2024 |
75.17% |
| Oct 31, 2023 |
55.07% |
| Jul 31, 2023 |
30.20% |
| Apr 30, 2023 |
68.13% |
| Jan 31, 2023 |
59.41% |
| Oct 31, 2022 |
48.66% |
| Jul 31, 2022 |
-999.25% |
| Apr 30, 2022 |
-876.41% |
| Jan 31, 2022 |
-3,118.48% |
| Oct 31, 2021 |
-2,736.39% |
| Jul 31, 2021 |
-675.22% |
| Apr 30, 2021 |
-1,889.70% |
